Azoles containing naphthalene with activity against Gram-positive bacteria: in vitro studies and in silico predictions for flavohemoglobin inhibition

Author(s):  
Suat Sari ◽  
Suna Sabuncuoğlu ◽  
Ebru Koçak Aslan ◽  
Ahmet Avci ◽  
Didem Kart ◽  
...  

2021 ◽  
Vol 72 (1) ◽  
pp. 79-95
Author(s):  
Awwad Abdoh Radwan ◽  
Fares Kaed Aanazi ◽  
Mohammed Al-Agamy ◽  
Gamal Mohammad Mahrous

Abstract Longstanding and firsthand infectious diseases are challenging community health threats. A new series of isatin derivatives bearing β-hydroxy ketone, chalcone, or spiro-heterocycle moiety, was synthesized in a good yield. Chemical structures of the synthesized compounds were elucidated using spectroscopic techniques and elemental analysis. Antibacterial activities of the compounds were then evaluated in vitro and by in silico modeling. The compounds were more active against Gram-positive bacteria, Staphylococcus aureus (MIC = 0.026–0.226 mmol L−1) and Bacillus subtilis (MIC = 0.348–1.723 mmol L–1) than against Gram-negative bacteria (MIC = 0.817–7.393 mmol L–1). Only 3-hydroxy-3-(2-(2,5-dimethylthiophen-3-yl)-2-oxoethyl)indolin-2-one (1b) was found as active as imipenem against S. aureus (MIC = 0.026 mmol L–1). In silico docking of the compounds in the binding sites of a homology modeled structure of S. aureus histidine kinase-Walk allowed us to shed light on the binding mode of these novel inhibitors. The highest antibacterial activity of 1b is consistent with its highest docking score values against S. aureus histidine kinase.



2020 ◽  
Vol 72 (7) ◽  
pp. 938-955
Author(s):  
Jessica Elena Mendieta‐Wejebe ◽  
Arianna Silva‐Trujillo ◽  
Martiniano Bello ◽  
Humberto L. Mendoza‐Figueroa ◽  
Norma Lizeth Galindo‐Alvarez ◽  
...  


2016 ◽  
Vol 19 (6) ◽  
pp. 489-496 ◽  
Author(s):  
Neetu Phougat ◽  
Anil Kumar Chhillar ◽  
Ashok Kumar Prasad ◽  
Nihar N. Senapati ◽  
Savita Khatri ◽  
...  


2017 ◽  
Vol 74 (4) ◽  
pp. 455-464 ◽  
Author(s):  
Yi Jin ◽  
Hubert Borell ◽  
Anne Gardin ◽  
Mike Ufer ◽  
Felix Huth ◽  
...  


Author(s):  
Devidas G. Anuse ◽  
Suraj N. Mali ◽  
Bapu R. Thorat ◽  
Ramesh S. Yamgar ◽  
Hemchandra K. Chaudhari

Background: Antimicrobial resistance is major global health problem, which is being rapidly deteriorating the quality of human health. Series of substituted N-(benzo[d]thiazol-2-yl)-2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)acetamide (3a-j) were synthesized from substituted N-(benzo[d]thiazol-2-yl)-2-chloroacetamide/bromopropanamide (2a-j) and 6-fluoro-3-(piperidin-4-yl)benzo[d]isoxazole (2) and further evaluated for their docking properties and antimicrobial activity. Methods: All synthesized compounds were characterized by FT-IR, NMR and Mass spectral analysis. All compounds were allowed to dock against different antimicrobial targets having PDB ID: 1D7U and against common antifungal target having PDB ID: 1EA1. Results: The compounds 3d and 3h were showed good activity against Methicillin-resistant Staphylococcus aureus (MRSA, resistance Gram-positive bacteria). All synthesized compounds showed good to moderate activity against selected bacterial and fungal microbial strains. If we compared the actual in-vitro antimicrobial activity and in-silico molecular docking study, we found that molecules 3i and 3h were more potent than the others. Conclusion: Our current study would definitely pave the new way towards designing and synthesis of more potent 2-aminobenzothiazoles derivatives.



2021 ◽  
pp. 105145
Author(s):  
Relja Suručić ◽  
Maja Travar ◽  
Miroslav Petković ◽  
BiljanaTubić ◽  
Miloš P. Stojiljković ◽  
...  


2021 ◽  
Vol 139 ◽  
pp. 111678
Author(s):  
Alexandru Sava ◽  
Frederic Buron ◽  
Sylvain Routier ◽  
Alina Panainte ◽  
Nela Bibire ◽  
...  


2021 ◽  
Vol 186 ◽  
pp. 112745
Author(s):  
Ereny M. Abdelmalek ◽  
Fazila Zulfiqar ◽  
Mohamed A. Albadry ◽  
Shabana I. Khan ◽  
Kumudini M. Meepagala ◽  
...  


2006 ◽  
Vol 50 (6) ◽  
pp. 2261-2264 ◽  
Author(s):  
Hee-Soo Park ◽  
Hyun-Joo Kim ◽  
Min-Jung Seol ◽  
Dong-Rack Choi ◽  
Eung-Chil Choi ◽  
...  

ABSTRACT DW-224a showed the most potent in vitro activity among the quinolone compounds tested against clinical isolates of gram-positive bacteria. Against gram-negative bacteria, DW-224a was slightly less active than the other fluoroquinolones. The in vivo activities of DW-224a against gram-positive bacteria were more potent than those of other quinolones.



Sign in / Sign up

Export Citation Format

Share Document